Publications
5529 Results
- Journal / Conference
- Cancer Treat Rep 65: 732-734
- Year
- 1981
- Research Committee(s)
- Melanoma
- Study Number(s)
- SWOG-7608
Sequential combination chemotherapy for disseminated melanoma: A Southwest Oncology Group study.
- Journal / Conference
- Cancer 47:1923-1929
- Year
- 1981
- Research Committee(s)
- Myeloma
- Study Number(s)
- SWOG-7305/7306, SWOG-7313, SWOG-7418
Chemoimmunotherapy for multiple myeloma.
- Journal / Conference
- In: Immunotherapy of Human Cancer. WD Terry, SA Rosenberg, eds. New York: Elsevier-North Holland, 61-66
- Year
- 1981
- Research Committee(s)
- Myeloma
- Study Number(s)
- SWOG-7704/05
Chemoimmunotherapy for multiple myeloma: Effect of Levamisole during maintenance. Preliminary report of a Southwest Oncology Group study.
- Journal / Conference
- 3rd NCI-EORTC Symposium on New Drugs in Cancer Therapy (October 15-17, 1981), #36
- Year
- 1981
- Research Committee(s)
- Breast, Gastrointestinal, Genitourinary, Gynecologic, Head and Neck, Lung, Melanoma, and Sarcoma
- Study Number(s)
- SWOG-7940/45, SWOG-8004, SWOG-8008, SWOG-8009, SWOG-8010, SWOG-8011, SWOG-8028, SWOG-8030, SWOG-8065
Southwest Oncology Group (SWOG) Phase II with mitoxantrone in non-hematologic malignancies.
- Journal / Conference
- Cancer Treat Rep 65:881-882
- Year
- 1981
- Research Committee(s)
- Sarcoma
- Study Number(s)
- SWOG-7731
Phase II trial of Anguidine in patients with sarcomas unresponsive to prior chemotherapy: A Southwest Oncology Group study.
- Journal / Conference
- AACR, #937
- Year
- 1981
- Research Committee(s)
- Sarcoma
- Study Number(s)
- SWOG-7729
High-dose Methotrexate (HDMTX) with Citrovorum Factor Rescue (CFR) plus vincristine (VCR) in advanced sarcoma.
- Journal / Conference
- ASCO, #C-751
- Year
- 1981
- Research Committee(s)
- Sarcoma
- Study Number(s)
- SWOG-7820
Maytansine in advanced sarcoma.
- Journal / Conference
- ASCO, #C-753
- Year
- 1981
- Research Committee(s)
- Sarcoma
- Study Number(s)
- SWOG-7911
Phase II evaluation of gallium nitrate (NSC-15200) in soft tissue and bone sarcomas.
- Journal / Conference
- Cancer Treat Rep 64: 675-677
- Year
- 1980
- Research Committee(s)
- Breast
- Study Number(s)
- SWOG-7809
Minimal single agent activity of Maytansine in refractory breast cancer
- Journal / Conference
- ASCO #C-199
- Year
- 1980
- Research Committee(s)
- Multiple sites
- Study Number(s)
- SWOG-7963